Original Article| Volume 3, ISSUE 4, P289-296, August 2009

Download started.


Serum 25-hydroxyvitamin D is independently associated with high-density lipoprotein cholesterol and the metabolic syndrome in men and women


      Low vitamin D status has been associated with markers of cardiovascular disease risk.


      This cross-sectional study assessed the relationships between serum 25-hydroxyvitamin D [25(OH)D] and selected markers for cardiovascular disease risk, including metabolic syndrome and its components, in adult men and women.


      Fasting blood samples, anthropometric measurements, and blood pressure were assessed in 257 men and women. Dietary intake was assessed with food frequency and dietary supplement questionnaires.


      Total vitamin D intake and that from dietary supplements were significantly associated with increasing serum 25(OH)D tertile (both P < .001). Mean±SEM serum high-density lipoprotein cholesterol (HDL-C) increased in a graded fashion (P < .001) from the lowest (48.4±1.8 mg/dL) to the highest (62.3±2.1 mg/dL) 25(OH)D tertile. The relationship between 25(OH)D and HDL-C remained significant (P < .001) after adjustment for established determinants of the HDL-C, with each 10-ng/mL increase in 25(OH)D associated with a 4.2-mg/dL increase in HDL-C concentration. Serum triglycerides (P=.008), waist circumference (P < .001), and body mass index (P < .001) showed graded, inverse relationships with 25(OH)D tertile, and the prevalence of metabolic syndrome decreased significantly from the lowest to the highest 25(OH)D tertile (31%, 14%, and 10%, respectively, P for trend=.001).


      Lower serum 25(OH)D is associated with the metabolic syndrome and adverse values for some metabolic syndrome risk factors, particularly the HDL-C concentration. Research is warranted to assess whether increasing vitamin D intake will improve the metabolic cardiovascular risk factor profile.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Clinical Lipidology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Heaney R.P.
        Functional indices of vitamin D status and ramifications of vitamin D deficiency.
        Am J Clin Nutr. 2004; 80: 1706S-1709S
        • Giovannucci E.
        Can vitamin D reduce total mortality?.
        Arch Intern Med. 2007; 167: 1709-1710
        • Wang T.J.
        • Pencina M.J.
        • Booth S.L.
        • et al.
        Vitamin D deficiency and risk of cardiovascular disease.
        Circulation. 2008; 117: 503-511
        • Martini L.A.
        • Wood R.J.
        Vitamin D status and the metabolic syndrome.
        Nutr Rev. 2006; 64: 479-486
        • Botella-Carretero J.I.
        • Alvarez-Blasco F.
        • Villafruela J.J.
        • Balsa J.A.
        • Vázquez C.
        • Escobar-Morreale H.F.
        Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity.
        Clin Nutr. 2007; 26: 573-580
        • Smotkin-Tangorra M.
        • Purushothaman R.
        • Gupta A.
        • Nejati G.
        • Anhalt H.
        • Ten S.
        Prevalence of vitamin D insufficiency in obese children and adolescents.
        J Pediatr Endocrinol Metab. 2007; 20: 817-823
        • Dobnig H.
        • Pilz S.
        • Scharnagl H.
        • et al.
        Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality.
        Arch Intern Med. 2008; 168: 1340-1349
        • Giovannucci E.
        • Liu Y.
        • Hollis B.W.
        • Rimm E.B.
        25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study.
        Arch Intern Med. 2008; 168: 1174-1180
        • Hyppönen E.
        • Boucher B.J.
        • Berry D.J.
        • Power C.
        25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort.
        Diabetes. 2008; 57: 298-305
        • Liu E.
        • Meigs J.B.
        • Pittas A.G.
        • et al.
        Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults.
        J Nutr. 2009; 139: 329-334
        • Holick M.F.
        • Chen T.C.
        Vitamin D deficiency: a worldwide problem with health consequences.
        Am J Clin Nutr. 2008; 87: 1080S-1086S
        • Lee J.H.
        O'Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?.
        J Am Coll Cardiol. 2008; 52: 1949-1956
      1. Dietary Reference Intakes. National Academy of Sciences. Institute of Medicine. Food and Nutrition Board. DRI table for biotin, choline, folate, niacin, pantothenic acid, riboflavin, thiamin, vitamin A, vitamin B6, vitamin B12, vitamin C, vitamin D, vitamin E and vitamin K. Available at: Accessed July 14, 2009.

        • Autier P.
        • Gandini S.
        Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials.
        Arch Intern Med. 2007; 167: 1730-1737
        • Hathcock J.N.
        • Shao A.
        • Vieth R.
        • Heaney R.
        Risk assessment for vitamin D.
        Am J Clin Nutr. 2007; 85: 6-18
        • Block G.
        • Jensen C.D.
        • Norkus E.P.
        • et al.
        Usage patterns, health, and nutritional status of long-term multiple dietary supplement users: a cross-sectional study.
        Nutr J. 2007; 6: 30
        • Jacques P.F.
        • Felson D.T.
        • Tucker K.L.
        • et al.
        Plasma 25-hydroxyvitamin D and its determinants in an elderly population sample.
        Am J Clin Nutr. 1997; 66: 929-936
        • Burgaz A.
        • Akesson A.
        • Oster A.
        • Michaëlsson K.
        • Wolk A.
        Associations of diet, supplement use, and ultraviolet B radiation exposure with vitamin D status in Swedish women during winter.
        Am J Clin Nutr. 2007; 86: 1399-1404
        • Sallis J.F.
        • Haskell W.L.
        • Wood P.D.
        • et al.
        Physical activity assessment methodology in the Five-City Project.
        Am J Epidemiol. 1985; 121: 91-106
        • Willett W.C.
        • Reynolds R.D.
        • Cottrell-Hoehner S.
        • Sampson L.
        • Browne M.L.
        Validation of a semi-quantitative food frequency questionnaire: comparison with a 1-year diet record.
        J Am Diet Assoc. 1987; 87: 43-47
      2. National Cholesterol Education Program Expert Panel, Third Report. Detection, evaluation, and treatment of high cholesterol in adults (Adult Treatment Panel III). NIH Publication 02–5215. Available at: Accessed July 15, 2009.

        • Friedewald W.T.
        • Levy R.I.
        • Fredrickson D.S.
        Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.
        Clin Chem. 1972; 18: 499-502
        • Kadish A.H.
        • Hall D.A.
        A new method for the continuous monitoring of blood glucose by measurement of dissolved oxygen.
        Clin Chem. 1965; 11: 869-875
        • Schmidt-Gayk H.
        • Bouillon R.
        • Roth H.J.
        Measurement of vitamin D and its metabolites (calcidiol and calcitriol) and their clinical significance.
        Scand J Clin Lab Invest Suppl. 1997; 227: 35-45
        • Grundy S.M.
        • Brewer Jr., H.B.
        • Cleeman J.I.
        • Smith Jr., S.C.
        • Lenfant C.
        • American Heart Association
        National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.
        Circulation. 2004; 109: 433-438
        • Hollis B.W.
        • Wagner C.L.
        • Drezner M.K.
        • Binkley N.C.
        Circulating vitamin D3 and 25-hydroxyvitamin D in humans: An important tool to define adequate nutritional vitamin D status.
        J Steroid Biochem Mol Biol. 2007; 103: 631-634
        • Gordon D.J.
        • Probstfield J.L.
        • Garrison R.J.
        • et al.
        High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
        Circulation. 1989; 79: 8-15
        • Reis J.P.
        • von Mühlen D.
        • Kritz-Silverstein D.
        • Wingard D.L.
        • Barrett-Connor E.
        Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults.
        Diabetes Care. 2007; 30: 1549-1555
        • Melamed M.L.
        • Michos E.D.
        • Post W.
        • Astor B.
        25-hydroxyvitamin D levels and the risk of mortality in the general population.
        Arch Intern Med. 2008; 168: 1629-1637
        • Ford E.S.
        • Ajani U.A.
        • McGuire L.C.
        • Liu S.
        Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults.
        Diabetes Care. 2005; 28: 1228-1230
        • Wortsman J.
        • Matsuoka L.Y.
        • Chen T.C.
        • Lu Z.
        • Holick M.F.
        Decreased bioavailability of vitamin D in obesity.
        Am J Clin Nutr. 2000; 72: 690-693
        • Leiter L.A.
        • Lewanczuk R.Z.
        Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
        Am J Hypertens. 2005; 18: 121-128
        • Wei Y.
        • Sowers J.R.
        • Clark S.E.
        • Li W.
        • Ferrario C.M.
        • Stump C.S.
        Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-kappaB activation via NADPH oxidase.
        Am J Physiol Endocrinol Metab. 2008; 294: E345-E351
        • Rammos G.
        • Tseke P.
        • Ziakka S.
        Vitamin D, the renin-angiotensin system, and insulin resistance.
        Int Urol Nephrol. 2008; 40: 419-426
        • Gómez J.M.
        The role of insulin-like growth factor I components in the regulation of vitamin D.
        Curr Pharm Biotechnol. 2006; 7: 125-132
        • Zemel M.B.
        Role of dietary calcium and dairy products in modulating adiposity.
        Lipids. 2003; 38: 139-146
        • Zemel M.B.
        Role of calcium and dairy products in energy partitioning and weight management.
        Am J Clin Nutr. 2004; 79: 907S-912S
        • Lips P.
        Which circulating level of 25-hydroxyvitamin D is appropriate?.
        J Steroid Biochem Mol Biol. 2004; 89–90: 611-614
        • Judd S.E.
        • Nanes M.S.
        • Ziegler T.R.
        • Wilson P.W.
        • Tangpricha V.
        Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the third National Health and Nutrition Examination Survey.
        Am J Clin Nutr. 2008; 87: 136-141
        • Pfeifer M.
        • Begerow B.
        • Minne H.W.
        • Nachtigall D.
        • Hansen C.
        Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women.
        J Clin Endocrinol Metab. 2001; 86: 1633-1637
        • Gunther S.
        • Patterson R.E.
        • Kristal A.R.
        • Stratton K.L.
        • White E.
        Demographic and health-related correlates of herbal and specialty supplement use.
        J Am Diet Assoc. 2004; 104: 27-34